Skip to main content
Fig. 5 | Health and Quality of Life Outcomes

Fig. 5

From: Health state utility estimates for value assessments of novel treatments in Huntington’s disease: a systematic literature review

Fig. 5

Comparison of published SF-6D utility scores for patients with HD

HD = Huntington’s disease; SF-6D = short-form 6-dimension; TFC = total functional capacity

Note: Error bars represent 95% confidence intervals derived from reported standard deviation and sample size (size of diamond represents the sample size). Country refers to location of residence of study participants

a Range for published mean SF-6D utility for general US population of ages 35 to 64 years [49]

Back to article page